Utilizing pharmacotherapy and mesenchymal stem cell therapy to reduce inflammation following traumatic brain injury

Utilizing pharmacotherapy and mesenchymal stem cell therapy to reduce inflammation following traumatic brain injury

The pathologic process of chronic phase traumatic brain injury is associated with spreading inflammation, cell death, and neural dysfunction. It is thought that sequestration of inflammatory mediators can facilitate recovery and promote an environment that fosters cellular regeneration. Studies have...

Full description

Bibliographic Details
Main Authors: Sherwin Mashkouri, Marci G Crowley, Michael G Liska, Sydney Corey, Cesar V Borlongan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Neural Regeneration Research
Subjects:
stem cells; drugs; neuroinflammation; trauma; neuroprotection; regeneration
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=9;spage=1379;epage=1384;aulast=Mashkouri

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=9;spage=1379;epage=1384;aulast=Mashkouri

Similar Items